West Pharmaceutical targets 5%-7% organic revenue growth for 2026 as HVP demand accelerates
Source: SeekingAlpha
2026-02-12 14:16:43 ET
More on West Pharmaceutical
- West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript
- West Pharmaceutical Services, Inc. 2025 Q4 - Results - Earnings Call Presentation
- West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript
- West Pharmaceutical beats Q4 street views, gives FY outlook
- West Pharmaceutical Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates
West Pharmaceutical Services Inc.
NASDAQ: WST
WST Trading
-5.11% G/L:
$231.95 Last:
605,786 Volume:
$240.39 Open:
WST Latest News
WST Stock Data
$17,698,798,786
71,223,978
N/A
370
N/A
Biotechnology & Life Sciences
Healthcare
US
Exton
